« Back to results
  • Added 7 Mar 2016
  • Expires

Identify neutralizing antibodies for medicine development

Details

Based on the edge-cutting antibodies screening technologies developed in our lab initially for HIV and later for Ebola, we think we can extend this systematic technologies to Zika with a great chance to find an effective neutralizing antibody used for Zika disease treatment and vaccine design. Here some publications from our and our collaborates labs, which mentioned our technologies: http://www.ncbi.nlm.nih.gov/pubmed/26879974 http://www.ncbi.nlm.nih.gov/pubmed/24623130 We are looking for global collaborates who have resources of patient samples, like blood or PBMCs. Thanks

Inclusion Criteria

We are looking for Zika patient samples, like blood or PBMCs. The samples are from patients who have been confirmed with Zika infection previously

Further information

We are looking for global collaborates who have resources of Zika patient samples, like blood or PBMCs.

Contact

wangy@ibbr.umd.edu

Respond to this study

Please Login to respond to a study.